Skip to main content

Cocaine Use clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder

    open to eligible people ages 18-65

    EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, metyrapone (Metopirone®), and the benzodiazepine receptor agonist, oxazepam (original trade name Serax®; now marketed as oxazepam (generic) only). This is a Phase 2 study in approximately 80 adult subjects with moderate-to-severe Cocaine Use Disorder (CUD).

    at UCSD

Last updated: